Mexican President Claudia Sheinbaum Pardo rejected the “White House's slander” against her government after Donald Trump's tariff order.

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval is an ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.

The FDA has approved Vertex Pharmaceuticals’ Journavx, a new pain medication designed to reduce the risk of addiction and overdose associated with opioids. Intended for short-term pain after surgeries ...

The US Food and Drug Administration has approved the first-ever non-opioid pain reliever in more than two decades.According ...

Application of a multi-stacked fentanyl patch could result in serious, life-threatening, or fatal respiratory depression.

U.S. needs to pursue evidence-based interventions for substance use disorders. It’s unclear to what degree the Trump ...

Doctors from the Cleveland Clinic talk about how this new non-opioid pain medication could help reduce the issue of opioid addiction in the United States.

Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...

Former Mesa County Commissioner Janet Rowland is leaving Mesa County for a new role in Montrose County as facilitator for the ...